人人干人人摸人人骑-人人干人人澡-人人干天天搞夜夜爽-人人干综合-人人搞人人摸-人人搞人人模

Gene Therapy
The Gene Editing Technology Innovation Platform
Hematopoietic Stem Cell Platform

Gene Editing Technology Innovation Platform

Gene Editing Technology Innovation Platform

The Gene Editing Technology Innovation Platform (CRISTARS®) is dedicated to developing international leading gene editing tools, obtaining core technologies with independent intellectual property rights, and paving the important foundation for gene editing technology translation. The platform is based on the combination of different single-stranded DNA deaminase structural domains and Cas9 nickase to develop a new generation of DNA base editing tools for broader and more accurate gene editing. The platform has successfully created the world-leading dual base editor and the ultra-high activity cytidine single-base editor (hyper CBE, HyCBE), which can efficiently convert two bases, improve editing activity and broaden the target range. The research results have been published in high-impact peer-review journals such as Nature Biotechnology, Nature Cell Biology, and Cell Research.

World's first successful application of CRISPR/Cas9 for mammalian gene editing

Gene editing is a technology to modify genes with precise modifications, which can be achieved with high efficiency and specificity for specific genomic DNA (or RNA), just as freely and accurately as editing text. In August 2013, a team of Bioraylab scientists published in the prestigious international journal Nature Biotechnology (IF≈43.11) the description of The CRISPR/Cas9 system was successfully used to edit genes in mice and rats. In the years since, Bioraylab scientists have continued to improve the gene editing system, applying it to a variety of applications including gene therapy, cell therapy and humanized animals.

The development of the era of gene therapy

In 2023, the world's first all human targeted BCMA CAR-T therapy "FUCASO" (Equecabtagene Autoleucel) was approved for sale in China for the treatment of recurrent or refractory multiple myeloma (R/R MM)
In 2022, Cilta cel, the first CAR-T cell therapy for the treatment of r/r MM in China, was approved by the FDA for marketing
In 2021, China's first CAR-T product, Aquilensai injection, was approved for marketing by the Chinese NMPA for post-treatment relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
In 2020，CRISPR/Cas9 gene editing technology wins Nobel Prize in Chemistry
In June 2019, zynteglo, the world's first gene therapy drug ,was approved for marketing by the EU EMA for the treatment of thalassemia
In May 2019, Zolgensma, the world's first gene therapy drug,was approved for marketing by the FDA for the treatment of SMA
In 2018, the first CRISPR/Cas9-based in vivo gene therapy clinical trial (EDIT-101) was approved by the FDA for the treatment of Leber Congenital Amaurosis Type 10 (LCA)
In 2017, Kymriah, the world's first CAR-T product, received FDA approval to market for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL)
In 2016, the first generation of single-base editors were developed
In November 2013, the third generation gene editing technology CRISPR/Cas9 (clustered regularly spaced short palindromic repeats) was introduced
In 2012, Glybera, the world's first AAV gene therapy drug, was approved for marketing by the EU EMA for the treatment of lipoprotein lipase deficiency (LPLD)
In 2010, TALENs (transcription activation-like effector nucleases), a second-generation gene editing technology, was introduced
In 2003, Gendicine, the world's first gene therapy drug, was approved for marketing by the NMPA in China for the treatment of head and neck squamous cell carcinoma (HNSCC)
In 2001, the first generation of gene editing technology ZFNs (zinc finger nucleases) was introduced
In 1990, the world's first clinical trial of gene therapy was approved by the FDA for the treatment of adenosine deaminase deficiency (ADA-SCID)
Back to top
主站蜘蛛池模板： 国产色按摩在 | 91性高湖久久久久久久久百人 | 视频一区视频二区91视频 | 国产精品日本一区二区不卡视频 | 河南人真人性做爰视频 | 国产精品第3页 | 亚洲AV无码一区二区乱子伦AS | 国产老师娇喘喷白浆在线播放 | 老司机成人永久精品视频 | 99国产精品一区二区毛卡片色戒 | 国产清纯美 | 亚洲午夜精品久久久久久成年 | 91香蕉香蕉碰碰人妻国产欧美 | 日本免费网址大全在线观看 | 亚洲欧美精品午睡沙发 | 成人av鲁丝片一 | 国产熟女毛多水大高潮 | 一区二区三区在 | 亚洲欧美一区二区三 | 成年网站在线观看播放 | 日韩精品亚洲春色欧美激情 | 成人avwww| 亚洲性爱无码视 | 91精品孕妇哺乳期国产 | 中文字幕国产在线电影 | 日韩在线观看网站 | 性生大片免费观看网站 | 奇米影视大全国产av | 精品毛片| 97中文字幕第十五 | 国产熟女一区二区三区浪潮 | A片免费观看60分钟吃奶 | 亚洲精品日韩专区在线观看 | 日韩精品福利资源网站在线 | 另类熟女伦乱视频 | 中文字幕久荜一区 | 国产欧美日本韩高清视频一区 | 足控网站av。com | 最新日韩高清无码 | 麻豆视频91传媒视频在线观看 | 国产真实乱 |